Pipeline
Significant opportunity for indication expansion
Preclinical evidence provides proof-of-concept in a range of highly prevalent musculoskeletal degenerative conditions.
Contact Us
Our team can help to answer any of your questions.
Get in touch to learn more about Doron Therapeutics.